The MHC class II transactivator CIITA induction as a potential new tool to develop anti-tumor vaccines and predict the efficacy of immunotherapy

Experimental and Molecular Pathology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles